13827
The efficacy of the activated LN cells is augmented when the sensitizing tumor is a genetically modified variant (designated D5G6 ) that secretes granulocyte/macrophage-colony-stimulating factor .
 ( cell line: genetically modified variant, None) , ( cell type: activated LN cells, None) , ( protein: granulocyte/macrophage-colony-stimulating factor, None) , ( cell type: LN cells, None) , ( cell line: D5G6, None) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: RNA,cell type,protein,cell line,DNA, Arguments type: . 
Text: {0} 
Answer:
 ( cell line: genetically modified variant, None) , ( cell type: activated LN cells, None) , ( protein: granulocyte/macrophage-colony-stimulating factor, None) , ( cell type: LN cells, None) , ( cell line: D5G6, None) 